Celularity Inc. Files 8-K Report
Ticker: CELUW · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1752828
Sentiment: neutral
Topics: 8-K, corporate-filing, financial-reporting
Related Tickers: CELU
TL;DR
Celularity filed an 8-K on Feb 24, 2025. Standard corporate update.
AI Summary
Celularity Inc. filed an 8-K on February 24, 2025, reporting other events and financial statements. The company, previously known as GX Acquisition Corp., is incorporated in Delaware and has its principal executive offices in Florham Park, New Jersey.
Why It Matters
This filing provides an update on Celularity Inc.'s corporate activities and financial reporting to the SEC, which is important for investors to track the company's status.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate reporting and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former Company Name
- February 24, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Florham Park, New Jersey (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Celularity Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of February 24, 2025.
When was Celularity Inc. incorporated, and in which state?
Celularity Inc. is incorporated in Delaware.
What was Celularity Inc.'s former company name?
Celularity Inc.'s former company name was GX Acquisition Corp.
Where are Celularity Inc.'s principal executive offices located?
Celularity Inc.'s principal executive offices are located at 170 Park Ave, Florham Park, New Jersey, 07932.
What is the SEC file number for Celularity Inc.?
The SEC file number for Celularity Inc. is 001-38914.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding Celularity Inc (CELUW).